These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28885307)

  • 21. Managing renal complications in multiple myeloma.
    Fotiou D; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid reduction of extremely high kappa free light chains in a patient with myeloma cast nephropathy.
    Snozek CLH; Kinard TN; Adamski J
    J Clin Apher; 2018 Jun; 33(3):439-443. PubMed ID: 29427353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thirteen treated of acute renal failure secondary to multiple myeloma with high cut off filters.
    Berni Wennekers A; Martín Azara MP; Dourdil Sahun V; Bergasa Liberal B; Ruiz Laiglesia JE; Vernet Perna P; Alvarez Lipe R
    Nefrologia; 2016; 36(4):418-26. PubMed ID: 27255910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL Amyloidosis.
    Sato S; Tamai Y; Okada S; Kannbe E; Takeda K; Tanaka E
    Intern Med; 2018 Feb; 57(3):399-402. PubMed ID: 29093392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
    Rutten KHG; Raymakers RAP; Minnema MC
    Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
    Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
    Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The kidney in dysproteinemia].
    Spanti D; Marcantoni C; Di Landro D
    G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities.
    Davenport A; Merlini G
    Nephrol Dial Transplant; 2012 Oct; 27(10):3713-8. PubMed ID: 23114897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma].
    Gorchakova SV; Rekhtina IG; Iatskov KV; Sukhanova GA; Golitsina EP; Varshavskiĭ VA; Biriukova LS
    Ter Arkh; 2009; 81(7):78-82. PubMed ID: 19708580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmapheresis in cast nephropathy: yes or no?
    Madore F
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):177-82. PubMed ID: 25590785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research Advances in Treatment of Myeloma Nephropathy-Review].
    Zhang XP; Xia ZY; Chen BA; Gao C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):613-616. PubMed ID: 28446322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
    Shum HP; Chan KC; Chow CC; Kho BC; Yan WW
    Hong Kong Med J; 2010 Dec; 16(6):489-92. PubMed ID: 21135429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma.
    Akilesh S; Alem A; Nicosia RF
    Hum Pathol; 2014 Apr; 45(4):875-9. PubMed ID: 24439928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A risk stratification for systemic immunoglobulin light-chain amyloidosis with renal involvement.
    Li T; Huang X; Wang Q; Zhao L; Ren G; Chen W; Zheng C; Zhou M; Jiang Q; Yin R; Liu Z
    Br J Haematol; 2019 Nov; 187(4):459-469. PubMed ID: 31348519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal proteins and renal disease.
    Kyle RA
    Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
    Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
    Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.